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Two proteins of the 40s ribosomal subunit were shown to be phosphorylated m vitro by a vaccmia vnus-encoded sermelthreonine protein kinase. 
These were identified by two-dimensional gel electrophoresls as ribosomal protems Sa and S2 and were shown by phosphoamino acid analysis to 
both be phosphorylated on serme and threonine residues. The three phosphorylated forms of S2 produced by the BlR protein kinase m vitro 
matched the phosphorylated forms of S2 previously observed in cells infected with vaccmia virus. These data strongly suggest that this enzyme 
is responsible for the phosphorylatlon of S2 and Sa which occurs early during vaccinia virus mfectlon 
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1. INTRODUCTION 
The protein encoded by vaccinia virus open reading 
frame (ORF) BlR is a serine/threonine protein kinase 
that is expressed early during infection and is packaged 
into virions [l-3]. A role for the BlR protein kinase in 
virus DNA replication has been proposed since two 
temperature-sensitive mutants, ts2 and ts25. which have 
a DNA negative phenotype at the non-permissive tem- 
perature, map to the BlR gene [4,5]. Infection of L cells 
with these ts mutants at the non-permissive temperature 
arrests prior to DNA replication and when cells infected 
at the permissive temperature are shifted to the non- 
permissive temperature in the midst of DNA replica- 
tion, DNA synthesis ceases [3.5]. Thus the Bl protein 
is required directly or indirectly throughout DNA repli- 
cation. Studies with other protein kinases have shown 
that these enzymes frequently have more than one sub- 
strate and biological role in vivo, so that although the 
BlR protein kinase plays an essential role in DNA rep- 
lication, other functions are possible. 
The activity of the B 1 R protein kinase has been dem- 
onstrated in vitro with artificial substrates such as ca- 
sein and histones but not with proteins that are 
phosphorylated during virus infection. These potential 
physiological substrates include both viral and cellular 
proteins [6,7]. Previous studies have demonstrated the 
phosphorylation of 40s ribosomal proteins Sa, S2 and 
S13 in cells early after infection with vaccinia virus and 
for S2 and S13 the phosphorylation occurs on serine 
and threonine residues [S-lo]. Virus infections in the 
presence of cycloheximide and cordycepin and the in 
vitro phosphorylation of ribosomes with protein ki- 
nase(s) derived from viral cores, have suggested a viral 
origin for the protein kinase responsible for the phos- 
phorylation of S2 and S13 [9,10]. Furthermore, protein 
kinase activities capable of phosphorylating S2 and S 13 
in vitro have been partially purified from the cytoplasm 
of infected cells [ll]. The function of these ribosomal 
protein phosphorylations is unknown, but their tempo- 
ral association with the switch to translation of viral 
mRNA suggests that they could have a role in this 
switch. The rat S2 ribosomal protein is encoded by a 
highly conserved repetitive gene family LLRep3 and is 
related to S. cerevisiae S4 and prokaryotic S5 ribosomal 
proteins [12]. These latter ribosomal proteins are in- 
volved in the binding of aminoacyl-tRNA to ribosomes 
and in conditioning the fidelity of translation and S2 
may serve a similar function in mammalian ribosomes 
[13]. Thus modification of translation seems a likely 
potential function of the vaccinia virus-induced ribo- 
somal protein phosphorylation. 
In this study we have investigated whether the BlR 
protein kinase is able to phosphorylate ribosomal pro- 
teins Sa, S2 or S13 in vitro and consequently might be 
the enzyme responsible for the ribosomal protein 
phosphorylations observed early during vaccinia virus 
infection. 
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2. MATERIALS AND METHODS 
1.1. Prepcrrutron of 40s rrbosornul suhuntts 
Rlbosomes were Isolated from rat hver, treated with 0.1 mM puro- 
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mycin for 15 mm at 37°C and dissociated mto subumts by centrtfuga- 
tton through a gradient of 1@30% sucrose m IO mM Tris-HCI (pH 
7.6). 0.5 M KCI. 5 mM MgCl, and 20 mM 2-mercaptoethanol at 
27 000 rpm for 4 h at 28°C m a Beckman SW28 rotor [13]. Samples 
were aliquoted and stored at -70°C. 
kinusr 
E co/r harboring plasmtd pAB6. whtch contams the BIR ORF 
under control of the bactertophage T7 promoter [I], were grown m the 
presence of 0.2% maltose to an OD,,,, of 0.5. The cells were then 
infected with phage 1 CE6 [14] at IO plaque formmg umts (pfu) per 
cell to induce BlR expression and were left unshaken for 20 min at 
room temperature for the phage to adsorb before bemg shaken at 
37°C for 2 h. Cells were harvested by centrtfugatton. washed in tce- 
cold PBS, resuspended m Ice-cold extraction buffer (50 mM Tris-HCI 
pH 7.5, IO mM DTT. 1 mM EDTA, 0.2% Trtton X-100, 1 mM PMSF. 
23 mg/ml aprotinm. 0.5pg/ml Ieupeptin. OSpg/mI pepstatm. O.S~g/ml 
chymostatin) and lysed by 2 x 7 s bursts from an ultrasonic dismtegra- 
tor (MSE IOOW) Cell debris was removed bycentrifugatton at 13 000 
rpm in a mtcrofuge for 5 mm at 3°C and the protem concentration 
of extracts was determined [I 51. 
Rtbosomal4OS subunits (0.05 d J6,1 units/reactton) were phosphoryl- 
ated with 5 pg of the bactertal extract containing BIR m a 10~1 assay 
volume comprtsmg, 50 mM Tris pH 7. 5 mM MgCl,. 5 mM DTT. 1 
,Ki [y-Z’P]ATP and 5 PM ATP The reaction was stopped after 15 mm 
at 37°C by the addition of 10~1 of 2 x protein sample buffer (125 mM 
Trts-HCI pH 6.8. 4% sodium dodecylsulfate (SDS). 40% glycerol. 1 M 
2-mercaptoethanol, 0.002% Bromophenol blue). Samples were ana- 
lysed by SDS-polyacrylamide gel electrophoresis (PAGE) [I61 and 
autoradiography of the dried gel. 
Ribosomal proteins of the 40s subunit phosphorylated by bactert- 
ally expressed Bl R were resolved by SDS-PAGE on a 12% gel and 
electrophoretically transferred to an Immobtlon-P blotting mem- 
brane The “P-labeled bands were excised and briefly rinsed with 
dtstilled water before hydrolysis m 5 7 M HCI for 1 h at I IO”C. The 
supernatants were lyophihzed. resuspended in pH 1.9 buffer (50: 156. 
1794. 88% formic acid. glacial acetic acid. H?O) and phosphoammo 
acids were resolved by one-dtmensional electrophorests on a thin layer 
cellulose plate at pH 3.5 [17. 181 and detected by autoradiography 
Unlabeled pho\phonmmo acid standards were located by mnhydrm 
staining 
Basic rtbosomal proteins were resolved by PAGE tirst on a 15% gel 
at pH 8.7 (separatmg mamly on the basis of charge) and second on 
a 15% gel at pH 4 5 (scparatmg mainly on the basis of size) [I 91 Actdic 
rtbosomal proteins were resolved by isoelectric-focusing m a poly- 
acrylamide gel containing amphohnes m the pH range 3 559.0 fol- 
lowed by SDS-PAGE m the second dimension [20]. 
3. RESULTS 
To determine whether the vaccinia virus Bl R protein 
kinase expressed in E. coli was able to phosphorylate 
ribosomal proteins of the 40s subunit, bacterial extracts 
were incubated with 40s ribosomal subunits in the pres- 
ence of [y-“P]ATP. Fig. 1 shows that two ribosomal 
proteins are specifically phosphorylated by E. coli ex- 
tracts containing the BlR protein kinase (lane 2), but 
not by control extracts lacking this enzyme (lane 1). The 
sizes of these two proteins correspond well with the sizes 
46 
30 
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Fig. 1 Rtbosomal protein phosphorylation by the vaccinia virus BIR 
protein kmase 30s ribosomal subunits were incubated wtth extracts 
from E co/i cells expressmg Bl R (lane 2) or control cells (lane I). 
Phosphorylated protems were resolved by SDS-PAGE on a 15% gel 
and vtsuahzed by autoradtography. The positions of migration of 
“C-labeled protem standards arc shown (lane M) m kDa. 
of ribosomal proteins Sa and S2 which are 43 kDa and 
33 kDa, respectively. There was no “‘P-labeled protein 
of 17 kDa corresponding to ribosomal protein S13 
which is phosphorylated during vaccinia virus infection. 
The identities of the phosphorylated ribosomal pro- 
teins were examined by two-dimensional gel electropho- 
resis (Figs. 2 and 3). In each case panel A shows the 
proteins stained by Coomassie brilliant blue and panel 
B is an autoradiograph of the gel in panel A. Fig. 2 
shows the analysis of basic ribosomal proteins. Al- 
though the majority of ribosomal protein S2 (which is 
predominantly unlabelled carrier) migrates as a single 
form (panel A) there are three radioactive spots which 
correspond to phosphorylated derivatives of ribosomal 
protein S? of increasing acidity (panel B). These forms 
of S2 are very similar to the three major phosphorylated 
species of S2 found within vaccinia-infected cells [lo]. 
There was no detectable phosphorylation of ribosomal 
protein S13 (Fig. 2) consistent with the results of one- 
dimensional electrophoresis (Fig. 1). Ribosomal protein 
Sa is acidic [21.32] and consequently was not observed 
using this gel electrophoresis system. However. it was 
observed under conditions previously used to detect Sa 
in virus-infected cells [lo] although due to the low pH 
of electrophoresis in the first dimension the protein 
barely entered the gel (data not shown). Therefore, the 
number of phosphorylated derivatives of Sa were as- 
sessed by isoelectric focusing [20]. An hfr 43 K protein 
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Fig. 2. Characterization of basic ribosomal proteins phosphorylated 
arrows indrcate correspondmg positrons m the two frames. 
by the vaccmia virus BlR protein kinase. 40s rrbosomal subunits were 
incubated with extracts of E coli expressmg Bl R (sectron 2). carrier 
40s ribosomal subunits were added (10 A,,, umts) and the subumts 
sedimented through a cushion of 0.5 M sucrose at 50 000 rpm for 4 
h at 4°C in a Beckman Ti70 rotor. Protein was extracted [13] and 
subjected to two-dimensronal gel electrophoresis [19] Panel A. Gel 
stamed with Coomassre brrlliant blue Panel B Autoradrograph. The 
with an isoelectric point of approximately 5.0 was visu- 
alized by staining with Coomassie blue (Fig. 3A) and 
one major and one minor phosphorylated derivative 
migrated with slightly higher isoelectric points (Fig. 
3B). 
Next the amino acid residues which were phosphor- 
ylated on ribosomal proteins Sa and S2 by the BlR 
protein kinase were determined. These two ribosomal 
proteins were resolved by SDS-PAGE, electrophor- 
etically transferred to an Immobilon-P membrane, lo- 
cated by autoradiography, excised and acid hydrolysed. 
Fig. 4 shows the resultant phosphorylated amino acids 
which were resolved by high voltage electrophoresis and 
identified using unlabeled standards located by ninhy- 
drin staining. The vaccinia virus protein kinase clearly 
phosphorylated both ribosomal proteins Sa and S2 on 
serine and threonine residues. Ribosomal protein Sa 
(lane 1) was phosphorylated equally on serine and thre- 
onine residues whilst ribosomal protein S2 (lane 3) 
was phosphorylated predominantly on threonine resi- 
dues. 
I 
52 
Fig. 3. Characterization of acidic ribosomal proteins phosphorylated 
by the vaccinia vrrus BlR protein kinase. 40s ribosomal subunits were 
tilled water. 
treated as descrrbed m Fig. 2, but subjected to two-dimensional anal- 
ysis (section 2) [20]. Panel A. Photograph of gel stained with Coomas- 
sre brrlliant blue. Panel B Autoradiograph. The arrows indicate corre- 
sponding positions in the two frames. The &I, values are from molec- 
ular weight standards present in the second dimension and the rsoelec- 
trrc pomts were determmed by measurmg the pH of shces of a parallel 
first-drmensron gel after these had been equrlibrated wrth boiled drs- 
4. DISCUSSION 
Three ribosomal proteins of the 40s subunit, Sa, S2 
and S13, are specifically phosphorylated early during 
infection with vaccinia virus [&lo]. Although protein 
kinase activities capable of phosphorylating ribosomal 
proteins S2 and S13 in vitro have been partially purified 
from vaccinia virus infected cells [ll], the origin and 
identity of these enzymes is currently unknown. Here 
the vaccinia virus BlR protein kinase is shown to phos- 
phorylate ribosomal proteins Sa and S2. but not S13, 
on serine and threonine residues in vitro. 
Phosphorylation of ribosome protein S2 occurs early 
during vaccinia virus infection in the presence of cyto- 
sine arabinoside. an inhibitor of virus DNA replication 
[9]. This protein is initially phosphorylated on a serine 
residue within 10 min of infection and this event is 
independent of continuing transcription and protein 
synthesis, suggesting that a virion-associated protein 
kinase is responsible [9,10]. By 1 h post-infection the S2 
protein is further phosphorylated on three threonine 
29 
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Fig. 4. Phosphoammo acid analysis of phosphorylated ribosomal pro- 
teins Sa and S2 Extracts from E colicells expresGng BlR (lanes 1 and 
3) or from control cells (lanes 2 and 4) were used to phosphorylate 40s 
ribosomal protrms m vitro Phosphoammo acids were analysed as 
described m sectlon 3 for both rlbosomal proteins Sa (lane:, 1 and 2) 
and S2 (lanes 3 and 4). The posItIons of phosphoammo acid standards 
arc mdicated bq arrows. phosphoserme (P-Ser). phosphothreonme 
( P-Thr) and phosphotyroslne (P-Tyr) 
residues and this event is dependent upon early virus 
protein synthesis since it is inhibited by both cordycepin 
and cyclohexamide [9.10]. Data presented here suggest 
that the product of the BlR gene can perform these 
phosphorylations. Furthermore, the presence of the 
BlR protein kinase within virus particles and its expres- 
sion early during infection [l&3] are consistent with such 
activity. Surprisingly, although Bl R can phosphorylate 
S2 on both serine and threonine residues in vitro, pro- 
tein kinase activity from vaccinia virus cores only phos- 
phorylates S:! on serine residues. This might be due to 
the kinase activity from virus cores being mostly attrib- 
utable to proteins other than B 1 R which may be serine- 
specific [2]. Other possibilities are that BlR might only 
phosphorylate threonine residues after it has been mod- 
ified or the substrate might be inaccessible to the virion- 
associated enzyme. 
Little is known of the phosphorylation of the acidic 
ribosomal protein Sa which occurs early during infec- 
tion [lo]. In the in vitro assay described here Sa is more 
highly phosphorylated than S2 by BlR and the phos- 
phorylation of Sa occurs with equal intensity on both 
serine and threonine residues. The S2 kinase purified 
from infected cell extracts also phosphorylates Sa in 
vitro [26]. 
The BlR protein kinase did not phosphorylate ribo- 
30 
somal protein S13 under the conditions of this investiga- 
tion. ln vivo S13 phosphorylation occurs on a serine 
residue 1 to 2.5 hours post-infection during viral DNA 
synthesis [IO] suggesting that the S13 protein kinase is 
not packaged in the virion and is, or requires, a virus- 
encoded early or intermediate protein. It is unlikely that 
there is another vaccinia-encoded protein kinase re- 
sponsible for the phosphorylation of S13 in vivo be- 
cause B 1 R is the only ORF in the vaccinia virus genome 
(strain Copenhagen) that is likely to encode a protein 
with protein kinase activity [23]. Although there is an- 
other vaccinia ORF designated Bl2R. that is related to 
BlR and to some other protein kinases, the gene prod- 
uct was considered unlikely to have protein kinase activ- 
ity due to the poor conservation of several important 
motifs [24]. Moreover, the B13R protein expressed in E. 
coli does not have protein kinase activity under condi- 
tions in which the vaccinia Bl R protein kinase and a 
serine protein kinase from African swine fever virus are 
active [1,25] (A.H. Banham and G.L. Smith unpub- 
lished data). Another possibility is that the multiple 
threonine phosphorylations of S2 are a prerequisite to 
S 13 phosphorylation perhaps by the S2 kinase [lo]. Cer- 
tainly this is not the case in vitro as the BlR kinase 
phosphorylates S2 on multiple threonine residues with- 
out any subsequent phosphorylation of S13. It is very 
probable that different protein kinases are responsible 
for phosphorylating ribosomal proteins 53 and S13 be- 
cause the 52 protein kinase activity purified from in- 
fected cells (which also phosphorylates three sites on the 
ribosomal protein S2) has been separated from S13 ki- 
nase activity, although it still retains the ability to phos- 
phorylate ribosomal protein Sa [26]. 
This m vitro study shows that the vaccinia virus- 
encoded BIR protein kinase is able to reproduce the 
phosphorylated forms of ribosomal proteins Sa and S2 
observed in vaccinia virus-infected cells. This is the first 
identification of potential in vivo substrates for this 
protein kinase. It is noteworthy that although certain 
ribosomal proteins (e.g. ribosomal protein S6) are sub- 
strates for several protein kinases in vitro, ribosomal 
protein S2 has not been reported to be phosphorylated 
by any cellular kinases including the cyclic AMP-de- 
pendent protein kinase. protein kinase C or casein ki- 
nases I and II [13,27]. 
A possible function for the phosphorylation of ribo- 
somal protens early during vaccinia infection is to en- 
hance selective translation of virus mRNAs. The mech- 
anism by which vaccinia virus shuts off host protein 
synthesis is unclear, but it does not involve alteration of 
the eIF-4 cap-binding complex [28,39] and cap-depend- 
ent translation is not inhibited by mechanisms similar 
to those used by adenovirus and picornviruses (re- 
viewed by [30]). Poxvirus mRNAs synthesized late dur- 
ing infection have an unusual 5’ poly(A) sequence of up 
to 35 nucleotides [3 l-341 and similarly, some early virus 
mRNAs also have a 5’ oligo(A) sequence downstream 
Volume 321, number 1 FEBS LETTERS April 1993 
of the cap structure [35,36]. Perhaps ribosomal phos- 
phorylation is a novel mechanism for the selective trans- 
lation of such virus mRNAs. 
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